Edition:
United Kingdom

Odonate Therapeutics Says Qtrly Loss Per Share of $1.15


Wednesday, 24 Jul 2019 

July 24 (Reuters) - Odonate Therapeutics Inc ::ODONATE THERAPEUTICS ANNOUNCES FINANCIAL RESULTS FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2019.ODONATE THERAPEUTICS INC- QTRLY LOSS PER SHARE $1.15.ODONATE THERAPEUTICS INC- CONTINUE TO EXPECT TO COMPLETE ENROLLMENT IN CONTESSA IN H2 OF 2019 AND REPORT TOP-LINE RESULTS IN 2020. 

Company Quote

28.16
-1.09 -3.73%
18 Sep 2019